trupcr – Katalyst Wealth

[Stock note] – 3B Blackbio DX…rapidly growing Molecular Diagnostic company

December 31, 2024

Hello Sir, Hope you are doing well. I was recently reading about 3B Blackbio DX. For sometime, it has been under our radar because of its Diagnostic kits business – TRUPCR. This company was reporting 25-30 crore annual sales before Covid-19; however, in FY 21 its sales jumped up to Rs 227 crore with PAT of Rs 114 crore. With the normalization of Covid-19 impact, the company is again on a growth path with annual sales of Rs 90 crore. Below, we have…

[Stock note] – 3B Blackbio DX…fast growing company in the Diagnostic space

June 29, 2024

Hello Sir, Hope you are doing well. We have always enjoyed digging up really small companies in the market cap range of Rs 200 crore to Rs 1,000 crore. Earlier, we could even recommend a Rs 100 crore market cap stock to our Premium Members; however, now it’s almost impossible considering liquidity issues. For sometime, 3B Blackbio DX, formerly Kilpest India has been under our radar because of its Diagnostic kits business – TRUPCR. This company was reporting 25-30 crore annual sales before…

[Stock idea] – Kilpest India

October 15, 2022

Hello Sir,Hope you are doing well.We have always enjoyed digging up really small companies in the market cap range of Rs 20 crore to Rs 500 crore. Earlier, we could even recommend a Rs 100 crore market cap stock to our Premium Members; however, now it’s almost impossible considering liquidity issues. Nevertheless, it’s always good to read about such companies and an individual investor can always look for potential investment opportunitiesSo, for sometime, Kilpest India has been under our radar because of its Diagnostic…